Molecular Profiling, Prognostic Insights, and Immune Landscape Evaluation of NUDT16 in Clear Cell Renal Cell Carcinoma - Top-Institutions - MDSpire

Molecular Profiling, Prognostic Insights, and Immune Landscape Evaluation of NUDT16 in Clear Cell Renal Cell Carcinoma

  • By

  • Chen Chen

  • Zhuojing Hu

  • Wei Zhao

  • Yunbo Ma

  • Qinghua Xia

  • November 21, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Molecular Oncology
    • Urologic Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cancer Genomics
    • Immuno-Oncology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Molecular Medicine
    • Urologic Oncology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Molecular Biology
    • Urology

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Genomics
    • Immunotherapy

Original Source(s)

Molecular Profiling, Prognostic Insights, and Immune Landscape Evaluation of NUDT16 in Clear Cell Renal Cell Carcinoma

  • by Chen Chen, Zhuojing Hu, Wei Zhao, Yunbo Ma, Qinghua Xia

  • November 21, 2025

Related Content

Evaluating the Prognostic Nutritional Index in Renal Cell Carcinoma Patients: A Comprehensive Systematic Review and Meta-Analysis Update

Structural variation drives enhancer hijacking via 3D genome disruption in ccRCC

Dana-Farber Research News 12.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from November 16 - 30.

  • by

  • December 15, 2025

  • 19 min